| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/12/2013 | CA2482879C Transgenic high tryptophan plants |
| 02/12/2013 | CA2469715C Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/12/2013 | CA2464147C Promotion of somatic embryogenesis in plants by wuschel gene expression |
| 02/12/2013 | CA2462646C Adjuvanted meningococcus compositions |
| 02/12/2013 | CA2457226C Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 02/12/2013 | CA2452712C Methods for detection and quantification of analytes in complex mixtures |
| 02/12/2013 | CA2446258C Transgenic high tryptophan plants |
| 02/12/2013 | CA2442594C Vip3 pesticidal toxin from bacillus thuringiensis |
| 02/12/2013 | CA2429163C Marine actinomycete taxon for drug fermentation and product discovery |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/12/2013 | CA2398280C Epoxide polymer surfaces |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/12/2013 | CA2365903C Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 02/12/2013 | CA2345817C Novel methods for therapeutic vaccination |
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/12/2013 | CA2304350C Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/12/2013 | CA2289277C Targeted gene modification by parvoviral vectors |
| 02/12/2013 | CA2274490C Non-m non-o hiv strains, fragments and applications |
| 02/12/2013 | CA2230144C Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 02/07/2013 | WO2013020137A1 Saliva collection, processing, stabilization, and storage method |
| 02/07/2013 | WO2013020101A2 Cell free translation system for compound screening and related uses |
| 02/07/2013 | WO2013020097A1 Double-stranded oligonucleotide compounds for treating hearing and balance disorders |
| 02/07/2013 | WO2013020090A2 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM |
| 02/07/2013 | WO2013020087A2 Nucleic acid compositions, methods and kits for rapid pairing of affinity agents |
| 02/07/2013 | WO2013020078A1 Sequence-specific mrna interferase and uses thereof |
| 02/07/2013 | WO2013020057A1 Quantitative genomics of the relaxation response |
| 02/07/2013 | WO2013020044A1 Treatment of fibrosis using microrna-19b |
| 02/07/2013 | WO2013020019A2 Hypoxia-related gene signatures for cancer classification |
| 02/07/2013 | WO2013019982A2 Biosensing system with extended lifetime via cofactor recycling |
| 02/07/2013 | WO2013019932A1 Methods for treating immunosuppression |
| 02/07/2013 | WO2013019857A2 Method for improving the success rate of hematopoietic stem cell transplants |
| 02/07/2013 | WO2013019800A1 Vlps containing ligands and methods related thereto |
| 02/07/2013 | WO2013019759A1 Enzymatic preparation of 10 base to 50 kb double-strand dna reagent for sequencing with a nanopore-polymerase sequencing device |
| 02/07/2013 | WO2013019680A1 Cell-based materials and methods for defining pharmacogenetic differences in drug metabolism |
| 02/07/2013 | WO2013019647A1 Production of fatty acids and derivatives thereof having improved aliphatic chain length and saturation characteristics |
| 02/07/2013 | WO2013019625A2 Methods of using a bacterial glcnac-6-p 2'-epimerase to promote sialylation of glycoconjugates |
| 02/07/2013 | WO2013019604A2 Protein production method |
| 02/07/2013 | WO2013019600A1 Axmi279 pesticidal gene and methods for its use |
| 02/07/2013 | WO2013019461A1 Terminator sequence for gene expression in plants |
| 02/07/2013 | WO2013019456A1 Method for high-throughput screening of transgenic plants |
| 02/07/2013 | WO2013019411A1 Methods and compositions for targeted integration in a plant |
| 02/07/2013 | WO2013019098A1 Helicobacter pylori proteins for diagnostic kit and vaccine |
| 02/07/2013 | WO2013019075A2 Method of preparing nucleic acid molecules |
| 02/07/2013 | WO2013019053A2 Escherichia genus microorganism lacking eute gene or puuc gene and method for producing retinoid using same |
| 02/07/2013 | WO2013019052A2 Escherichia genus microorganism lacking or having amplified ybbo gene and method for producing retinoid using same |
| 02/07/2013 | WO2013019051A2 Method for producing retinoid from microorganism |
| 02/07/2013 | WO2013018969A1 Slide chip for food borne pathogen detection sensor and manufacturing method thereof |
| 02/07/2013 | WO2013018894A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | WO2013018892A1 Drug composition for cancer treatment and/or prevention |
| 02/07/2013 | WO2013018891A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | WO2013018889A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018885A1 Method for detecting pancreatic cancer |
| 02/07/2013 | WO2013018883A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018882A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | WO2013018880A1 Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
| 02/07/2013 | WO2013018879A1 Protein exhibiting fatty acid elongation promoting activity, gene encoding same and use thereof |
| 02/07/2013 | WO2013018866A1 Method for assessing myelodysplastic syndrome or myeloid tumor predisposition, polypeptide and antibody therefor, and candidate screening method for therapeutic drug or prophylactic drug therefor |
| 02/07/2013 | WO2013018836A1 Method for inhibiting non-specific binding in step of detecting substance in biological sample, and agent for use in the method |
| 02/07/2013 | WO2013018778A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct |
| 02/07/2013 | WO2013018734A1 Microorganism having carbon dioxide fixation pathway introduced thereinto |
| 02/07/2013 | WO2013018709A1 Phosphatidic acid phosphatase gene |
| 02/07/2013 | WO2013018690A1 Erap1-derived peptide and use thereof |
| 02/07/2013 | WO2013018260A1 METHOD FOR DISSOLVING PHTHALOCYANINE COMPOUND IN WATER USING G-quadruplex |
| 02/07/2013 | WO2013018096A1 Use of integrase for targeted gene expression |
| 02/07/2013 | WO2013018060A2 Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
| 02/07/2013 | WO2013017982A1 Method for identification and isolation of terminator sequences causing enhanced transcription |
| 02/07/2013 | WO2013017950A1 High throughput method for assembly and cloning polynucleotides comprising highly similar polynucleotidic modules |
| 02/07/2013 | WO2013017813A1 Methylotrophic yeast transformed with gal promoters |
| 02/07/2013 | WO2013017713A1 Hrsv f protein in the stabilised pre-fusion state and specific neutralising antibodies against same |
| 02/07/2013 | WO2013017683A1 Method for systemically influencing processes in the male meiocyte |
| 02/07/2013 | WO2013017672A1 Mammal sestrins in the treatment of muscle wasting |
| 02/07/2013 | WO2013017656A1 Antagonists of ribonucleases for treating obesity |
| 02/07/2013 | WO2013017644A1 A pentose sugar fermenting cell |
| 02/07/2013 | WO2013017542A1 Method for preventing or treating memory impairment and pharmaceutical compositions useful therefor |
| 02/07/2013 | WO2013017293A1 Powdery mildew resistance providing genes in cucumis sativus |
| 02/07/2013 | WO2013016896A1 Agrocybe aegerita lectin aal-2, and encoding gene thereof, preparation method therefor and application thereof |
| 02/07/2013 | WO2013016879A1 Method for batch cloning of genes |
| 02/07/2013 | WO2013016878A1 Method for cloning microbial genes |
| 02/07/2013 | WO2013016826A1 Transgenic non-human animal model of neurodegenerative disease |
| 02/07/2013 | WO2013016810A1 Organelle targeting nanocarriers |
| 02/07/2013 | WO2013016805A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | WO2012174529A3 Methods for increasing the potency and efficacy of stem cells |
| 02/07/2013 | WO2012169822A9 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 02/07/2013 | WO2012156976A8 Methods of producing artemisinin in non-host plants and vectors for use in same |
| 02/07/2013 | WO2012154735A3 Thermostable carbonic anhydrases and methods of use thereof |
| 02/07/2013 | WO2012145624A3 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies |
| 02/07/2013 | WO2012125652A3 Antibody and antibody mimetic for visualization and ablation of endogenous proteins |
| 02/07/2013 | WO2011153602A3 Recombinant e-ntpdases, use for producing a diagnostic kit for detecting antibodies in various types of leishmaniasis caused by species of the leishmania genus |
| 02/07/2013 | US20130036519 Compositions and Methods for the Control of Root Lesion Nematode |
| 02/07/2013 | US20130036517 Intein-modified enzymes, their production and industrial applications |
| 02/07/2013 | US20130036516 Plants having enhanced yield-related traits and method for making the same |
| 02/07/2013 | US20130036515 Banana MADS-Box Genes for Banana Ripening Control |
| 02/07/2013 | US20130036487 Pepper hybrid svr 11368833 |
| 02/07/2013 | US20130036486 Bean line fivc6v0999 |
| 02/07/2013 | US20130036485 Bean line fivc6v0998 |
| 02/07/2013 | US20130036484 Bean line fivc6v1002 |
| 02/07/2013 | US20130036483 Bean line fivc6v1001 |
| 02/07/2013 | US20130036482 Method for assessment of potential for development of dravet syndrome and use thereof |
| 02/07/2013 | US20130035513 Methods and compositions for enhanced production of fatty aldehydes and fatty alcohols |